NCT05187897 is a NA clinical trial of CHV-NEO in Neonatal Death, sponsored by University of Washington.

Who is sponsoring NCT05187897?

NCT05187897 is sponsored by University of Washington.

What drugs are being tested in NCT05187897?

Interventions in NCT05187897: CHV-NEO.

What condition does NCT05187897 study?

NCT05187897 studies Neonatal Death, Perinatal Death.

Is NCT05187897 still recruiting?

NCT05187897 is currently recruiting now. Last updated 11 December 2025.

Last reviewed 2025-12-11 · How we verify

NCT05187897

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CHV-NEO: Community-based Digital Communication to Support Neonatal Health

Recruiting now NA Last updated 11 December 2025

What this trial tests

NA trial testing CHV-NEO in Neonatal Death in 3,000 participants. Currently enrolling.

Timeline

10 January 2024

Primary endpoint
30 June 2026

30 June 2026

Quick facts

Lead sponsor	University of Washington
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	3,000
Start date	10 January 2024
Primary completion	30 June 2026
Estimated completion	30 June 2026
Sites	1 location across Kenya

Drugs / interventions tested

CHV-NEO

Conditions studied

Neonatal Death — all drugs for Neonatal Death →
Perinatal Death — all drugs for Perinatal Death →

Sponsor

University of Washington

Who can join

14 and older, female only, with Neonatal Death or Perinatal Death. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Neonatal mortality (defined as death in the first 28 days of life) remains unacceptably high in sub-Sarahan Africa. The concentrated risk of neonatal illness in the first weeks of life and its potential to rapidly deteriorate means that expanding mothers' access to timely information and support during this period is critical to reducing neonatal mortality. This cluster-randomized control trial aims to integrate a 2 way interactive SMS text messaging intervention into existing digital infrastructure supporting Community Health Volunteer (CHV) workflow in Western Kenya (dCHT) to enable remote communication by mothers with CHVs between home visits.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Proceedings of the 2023 International Maternal Newborn Health Conference.
· 2024 · cited 6× · PMID 38509552 · DOI 10.1186/s12919-024-00289-y
Digital communication between mothers and community health workers to support neonatal health (CHV-NEO): study protocol for a randomized controlled trial.
Ronen K, Pothan LC, Apondi V, Otieno FA, et al · · 2024 · PMID 39367450 · DOI 10.1186/s13063-024-08501-2

Verify or expand the search:

Other recruiting trials for Neonatal Death

Currently open trials in the same condition.

NCT06125860 — BEP Targeting Strategies in Ethiopia · NA · recruiting

Other University of Washington trials

Trials by the same sponsor.

NCT07430852 — Inherited and Environmental Risks Acting on Body Weight · NA · not yet recruiting
NCT07466498 — Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Canc · Phase 2 · not yet recruiting
NCT06422299 — Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Youn · NA · not yet recruiting
NCT07322341 — SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer · Phase 2 · not yet recruiting
NCT07332351 — Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05187897 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Washington
Last refreshed: 11 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05187897.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing